Analystreport

Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com